Trial Condition(s):

Postmenopause

Observational Trial Angeliq

Bayer Identifier:

SDG_2004.04

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

818

Trial Dates

August2004

July2005

Phase

N/A

Could I receive a placebo?

Products

Angeliq (E2/DRSP, BAY86-4891)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Locations

Trial Design

Anwendungsbeobachtung Angeliq

Trial Type:

Observational

Intervention Type:

N/A

Trial Purpose:

N/A

Allocation:

N/A

Blinding:

N/A

Assignment:

N/A

Trial Arms:

N/A

Primary Outcome

Timeframe:

Secondary Outcome

Timeframe:

Postmenopause

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

No Limit

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

Trial Design

Primary Outcome

Secondary Outcome

Additional Information